Navigation Links
Hyaluronic Acid Knee Procedures Grow 38% from Q3 2006 to Q3 2007

Orthopedic Surgeons and Rheumatologists Performing More Procedures

WALTHAM, Mass., Nov. 26 /PRNewswire/ -- Millennium Research Group's US Hyaluronic Acid (HA) Viscosupplementation Marketrack(TM) service, which captures data from both orthopedic surgeons and rheumatologists, shows that both groups provided more HA knee injections in Q3 2007 compared to Q3 2006. While treatments are growing in both groups, there are substantial differences in the products they use in these procedures.

In the survey sample, from Q3 2006 to Q3 2007, average quarterly orthopedic surgeon HA knee injection volumes jumped from 62 to nearly 85. Similarly, over the same time period, average quarterly HA knee injections for rheumatologists increased from 54 to over 75. Fueling this growth is the growing aging population, which is expanding the potential patient pool for HA viscosupplementation each year. In addition, expanding patient awareness of the benefits of HA viscosupplementation injections is also increasing the number of patients seeking and ultimately receiving treatment.

"While both groups' injection numbers are rising, they are using different products," says Kevin Flewwelling, Senior Analyst at MRG. "It turns out that in Q307, orthopedic surgeons mostly used Genzyme's Synvisc, which represented nearly 39% of the total injections administered by orthopedic surgeons. Rheumatologists, on the other hand, tended to use sanofi aventis' Hyalgan most often, which accounted for almost 36% of the total injections administered by this group."

When both groups were asked to rank the most important reasons for prescribing HA viscosupplementation, orthopedic surgeons ranked product efficacy as their number one reason, while rheumatologists reported long-term pain relief as their first priority.

About Hyaluronic Acid Viscosupplementation Marketrack(TM)

HA Viscosupplementation Marketrack(TM) gathers data from 260 orthopedic surgeons, rheumatologists, and other practitioners performing HA Viscosupplementation procedures throughout the US. Data is collected on a quarterly basis. Marketrack subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure volumes, distribution channels, competitors, and brand information (Hyalgan, Euflexxa, Orthovisc, Supartz, Synvisc, and others). The project also covers information on the competing corticosteroid markets.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

SOURCE Millennium Research Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an ... is bound to proteins, copper is also toxic to cells. With a $1.3 ... Institute (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas ...
(Date:11/24/2015)... Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider of ... , today announced that the company has set a new quarterly ... quarter on quarter growth posted for Q3 of 2014 to Q3 ... Mexico , with the establishment of an ... --> United Kingdom and ...
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), ... MultiGP, also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing ... AMA members have embraced this type of racing and several new model aviation pilots ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):